HomeStock ScreenerZenotech Laboratories

Zenotech Laboratories Current Share Price | Zenotech Laboratories Stock Screener

ZENOTECH Pharmaceuticals
Live Share Price BSE
₹44.24
▼ -0.76 (-1.69%)
2026-09-18 00:00:00
As of September 18, 2026, the live Zenotech Laboratories share price (BSE: ZENOTECH) is ₹44.24, down 1.69% from the previous close, with shares trading between ₹44.10 and ₹45.88 in today's trading session, and a 52-week range of ₹34.29–₹53.80. Browse Zenotech Laboratories annual reports to support your investment research. Use the Zenotech Laboratories stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Zenotech Laboratories Market Cap ₹271.56 Cr.
ZENOTECH P/E Ratio (TTM) -
Zenotech Laboratories P/B Ratio 2.87
EPS (TTM) ₹-0.18
Dividend Yield -
Debt to Equity -
ZENOTECH 52 Week High ₹53.80
Zenotech Laboratories 52 Week Low ₹34.29
Operating Margin -52.00%
Profit Margin -66.67%
ZENOTECH Revenue (TTM) ₹3.00
EBITDA ₹-1.00
Net Income ₹-2.00
Total Assets ₹111.00
Total Equity ₹95.00

Zenotech Laboratories Current Share Price Chart

Track the current Zenotech Laboratories share price and stock price with an interactive chart. Analyse ZENOTECH price trends, trading volume, historical performance, and volatility across different timeframes — the complete Zenotech Laboratories stock quote in one place.

Zenotech Laboratories Company Profile - Fundamental Screener

Screen Zenotech Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ZENOTECH shares.
Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E
ISIN INE486F01012

Zenotech Laboratories Balance Sheet Screener

Screen ZENOTECH balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017
Assets
Total Assets 111 111 106 101 94 86 86 85 82 51
Current Assets 41 36 26 16 7 7 6 19 31 2
Fixed Assets 62 61 66 65 71 74 49 43 44 47
Liabilities
Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 4 2 2 2 8 23 1 0 0 0
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0
Shareholders' Equity
Total Equity 95 96 91 82 71 48 50 39 42 -66
Share Capital 61 61 61 61 61 61 61 61 61 34
Reserves & Surplus 34 35 30 21 10 -13 -11 -22 -19 -100

Zenotech Laboratories Income Statement Screener - Profit & Revenue Analysis

Screen Zenotech Laboratories income statement and profit fundamentals. Analyze ZENOTECH quarterly results, revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Zenotech Laboratories share price evaluation.
Item 2006-Jun 2006-Sept
Revenue 3 6
Expenses 4 4
EBITDA -1 2
Operating Profit % -52.00% 24.00%
Depreciation 0 0
Interest 0 0
Profit Before Tax -2 1
Tax 0 0
Net Profit -2 1
EPS 0.00 0.00

Zenotech Laboratories Cash Flow Screener - Liquidity Fundamentals

Screen ZENOTECH cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March
Operating Activities 10 10 12 21 18 6 11 -14 -16 2
Investing Activities -7 15 -21 -6 -2 -5 -21 -16 -3 -1
Financing Activities 0 0 0 -6 -16 0 -3 15 47 -1
Net Cash Flow 4 25 -9 9 0 1 -12 -15 28 0

Zenotech Laboratories Shareholding Pattern Screener

See Zenotech Laboratories shareholding pattern with promoter, FII, and DII holdings. Check Zenotech Laboratories promoter holding and ownership changes for ZENOTECH on TickJournal.
Item 2026-Mar 2026-Jun 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun
Promoter Holding 68.84% 68.84% 68.84% 68.84% 68.84% 68.84% 68.84% 68.84%
FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%
Govt Holding 0.98% 0.98% 0.98% 0.98% 0.98% 0.98% 0.98% 0.98%
Public Holding 22.81% 22.81% 22.78% 22.78% 22.80% 22.78% 22.65% 22.72%
Other Holding 7.35% 7.36% 7.39% 7.38% 7.36% 7.38% 7.52% 7.45%
Shareholder Count 10,301 10,161 10,690 10,661 10,670 10,464 9,819 9,750

Zenotech Laboratories Share Dividend Screener - Share Yield Analysis

Check Zenotech Laboratories dividend history with payout and yield data. View Zenotech Laboratories dividend details including ex-dates and amounts for ZENOTECH stock.
No dividends declared by Zenotech Laboratories.

Zenotech Laboratories Stock Index Membership

See which indices include Zenotech Laboratories stock. Check ZENOTECH index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Zenotech Laboratories is not part of any tracked indices.
Only major market indices are tracked in our system.

Zenotech Laboratories Market Events Screener - Corporate Actions

Get Zenotech Laboratories corporate actions including splits, bonuses, and buybacks. Check Zenotech Laboratories stock events that may affect ZENOTECH share price.
Announcement Date Record Date Event Type Information Price Impact
2026-09-25 2026-09-25 Annual General Meeting NA -0.27%
2026-07-28 2026-07-28 Quarterly Result Announcement NA 1.14%
2026-04-29 2026-04-29 Quarterly Result Announcement NA -3.34%
2026-01-23 2026-01-23 Quarterly Result Announcement NA 0.56%
2025-10-31 2025-10-31 Quarterly Result Announcement NA 6.75%
2025-09-26 2025-09-26 Annual General Meeting NA -14.96%
2025-07-28 2025-07-28 Quarterly Result Announcement NA -0.16%
2025-04-25 2025-04-25 Quarterly Result Announcement NA -0.59%
2025-01-28 2025-01-28 Quarterly Result Announcement NA -5.92%
2024-10-23 2024-10-23 Quarterly Result Announcement NA -8.89%
2024-09-27 2024-09-27 Annual General Meeting NA 44.66%
2023-09-29 2023-09-29 Annual General Meeting NA 2.60%
2017-06-01 2017-06-02 Rights 17:22 -

Zenotech Laboratories Competitors Screener - Peer Comparison

Screen ZENOTECH competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 441,478 36.91 61,674 12.69% 11,565 34.00
Divis Laboratories 247,470 85.36 11,067 13.95% 2,568 63.65
Torrent Pharmaceuticals 188,872 86.95 13,886 20.34% 2,138 52.16
Zydus Life Science 112,608 24.28 27,658 17.64% 5,026 45.64
Cipla 110,352 33.22 29,045 2.24% 3,870 35.27
Laurus Labs 106,298 95.94 6,868 22.01% 890 68.28
Dr Reddys Laboratories 97,281 29.91 35,059 3.90% 4,158 47.72
Aurobindo Pharma 96,652 25.88 34,145 5.56% 3,503 57.04
Lupin 95,790 17.09 29,039 26.75% 5,356 28.17
Mankind Pharma 94,163 44.87 14,636 14.85% 1,938 37.57

Zenotech Laboratories Company Announcements - News Screener

Screen ZENOTECH latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
Date Update Actions
2026-08-29 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-28 Notice Of 37Th Annual General Meeting To Be Held On Friday September 25 2026 Along With Annual Report For The FY 2025-26. -
2026-08-28 Reg. 34 (1) Annual Report. -
2026-08-24 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-22 Intimation Of 37Th Annual General Meeting Of Zenotech Laboratories Limited -
2026-07-29 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-07-28 Board Meeting Outcome for Outcome Of The Board Meeting Held Today I.E. July 28 2026 -
2026-07-28 Unaudited Financial Results For The Quarter Ended June 30 2026 -
2026-07-14 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-07-13 Board Meeting Intimation for Considering And Approving Unaudited Standalone Financial Results Of The Company For The Quarter Ended June 30 2026. -
2026-06-30 Closure of Trading Window -
2026-05-27 Compliances-Reg.24(A)-Annual Secretarial Compliance -
2026-04-30 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-04-29 Audited Standalone Financial Results For The Quarter And Financial Year Ended March 31 2026 -
2026-04-29 Board Meeting Outcome for Outcome Of The Board Meeting Held On April 29 2026 -
2026-04-28 Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A -
2026-04-23 Board Meeting Intimation for Considering And Approving Audited Standalone Financial Results Of The Company For The Quarter And Financial Year Ended March 31 2026. -
2026-04-10 Clarification On Price Movement -
2026-04-10 Clarification sought from Zenotech Laboratories Ltd -
2026-04-07 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -